MichaelJamesDowningMD

Clinical Trials

• Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Major Depressive Disorder With Mixed Features - Extension Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01

  Completed

  Phase 2

• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Start of enrollment: 2013 Nov 01

  Completed

  Phase 3

• 12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01

  Completed

  Phase 3

• Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01

  Completed

  Phase 3

• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18

  Completed

  Phase 3

• This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia Start of enrollment: 2019 Apr 15

  Completed

  Phase 2

• Join now to see all